Regulatory Service and Support – Commercial Phase
- Compilation of the drug substance CTD sections of Module 1, 2 and 3 for a NDA/MAA submission
- The CTD sections can be prepared either in PolyPeptide’s template or in any client template
- Compilation and submission of DMF/ASMF in any market
- Compilation and submission for CEP (COS) certificate
- DMF/ASMF/CEP on file at regulatory authorities for many generic drug substances
- Access to open part DMF for client’s submission in less regulated markets
- Professional support in responding to review questions from regulatory authorities
- Life cycle maintenance of all regulatory dossiers, independent on the submission route
- Preparation and submission of variations and changes
- Advice and strategies for obtaining regulatory approval
- Close and transparent collaboration with clients